Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Simulation of dosimetry impact of 4DCT uncertainty in 4D dose calculation for lung SBRT

Fig. 5

\( \overline{\Delta {D}_{99}} \) (\( \overline{\Delta {D}_{95}} \)) varies with the a mean amplitude, b standard deviation of the amplitude, c mean period, d standard deviation of the period, e prescription dose level, and f target diameter. The static conditions are: a standard deviation of amplitude/mean amplitude: 0.25, mean period: 4 s, standard deviation of the period/mean period: 0.2, prescription dose level: 80% and target diameter: 3 cm; b mean amplitude: 15 mm, mean period: 4 s, standard deviation of the period/mean period: 0.2, prescription dose level: 80% and target diameter: 3 cm; c mean amplitude: 15 mm, standard deviation of the amplitude/mean amplitude: 0.25, mean period: 4 s, standard deviation of the period/mean period: 0.2, prescription dose level: 80% and target diameter: 3 cm; d mean amplitude: 15 mm, standard deviation of the amplitude/mean amplitude: 0.25, mean period: 4 s, prescription dose level: 80% and target diameter: 3 cm; e mean amplitude: 15 mm, standard deviation of the amplitude/mean amplitude: 0.25, mean period: 4 s, standard deviation of the period/mean period: 0.2, target diameter: 3 cm; f mean amplitude: 15 mm, standard deviation of the amplitude/mean amplitude: 0.25, mean period: 4 s, standard deviation of the period/mean period: 0.2, and prescription dose level: 80%

Back to article page